Price History
Feb 9, 2026 — Mar 30, 2026Investment Snapshot
- Trading 2% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 6/9 — moderate financial health
- ROE of 7.7% — below-average profitability
- Dividend yield of 2.4%
Innospec Inc. - Common Stock (IOSP) is a Basic Materials company operating in Chemicals & Allied Products, listed on the NASDAQ , with a market capitalisation of $1.8 billion . Key value metrics: P/E ratio 17.4, P/B ratio 1.35, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Innospec Inc. - Common Stock — Fundamental Analysis Summary
Innospec Inc. - Common Stock (IOSP) is currently trading 2% above its Graham Number of $70.61, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a reasonable trailing P/E ratio of 17.4x.
On financial health, IOSP shows a moderate Piotroski F-Score of 6/9, and modest return on equity of 7.7% (sector average: -1.2%), and manageable leverage with a debt-to-equity ratio of 0.38.
StockPik's composite Value Score for IOSP is 92/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
IOSP reports a moderate gross margin of 27.7% (sector average: 12.8%) and a modest operating margin of 7.3%.
IOSP shows revenue declining at 4% year-over-year, with earnings growing at 228%.
IOSP pays a modest dividend yield of 2.4%.